AKTS compared with HMH: revenue, margins and what each company keeps, and the suppliers and customers both name

AKTSAktis Oncology, Inc.

Mkt capRevenueRevenue

HMHHMH Holding Inc

Mkt capRevenueRevenue

Compare

AKTSAktis Oncology, Inc.

HMHHMH Holding Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AKTS3 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.0%▲+4.79%×0.28

May 12 '26—▲+7.99%—

Q1 FY26—▲+8.16%—

HMH1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.35%—

= impliedAKTS realized, solidHMH realized, hatchedOne scale, both sides: full bar = 17%× = |realized| ÷ impliedSource: market data

AKTSAktis Oncology, Inc.

14.58▼−8.45%· post 14.59

Mkt cap$880.9MRevenue$3MQ2 FY26

HMHHMH Holding Inc

17.24▼−8.95%· post 17.24

ClosedNov 2 '26

Mkt cap—Revenue$171MQ2 FY26

Compare

ClosedNov 2 '26

AKTSAktis Oncology, Inc.

HMHHMH Holding Inc

14.58▼−8.45%post 14.59

Price

17.24▼−8.95%post 17.24

$880.9M

Mkt cap

—

Q2 FY26$3M

Revenue

$171MQ2 FY26

AKTS14.58▼−8.45%vsHMH17.24▼−8.95%ClosedNov 2 '26